Lucid Diagnostics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LUCD and other ETFs, options, and stocks.About LUCD
Lucid Diagnostics, Inc. is a commercial-stage medical diagnostics technology company. It focuses on patients with gastroesophageal reflux disease also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma.
LUCD Key Statistics
Stock Snapshot
Lucid Diagnostics(LUCD) stock is priced at $1.21, giving the company a market capitalization of 157.97M. It carries a P/E multiple of -1.36.
During the trading session on 2026-02-09, Lucid Diagnostics(LUCD) shares reached a daily high of $1.22 and a low of $1.18. At a current price of $1.21, the stock is +2.1% higher than the low and still -1.2% under the high.
Trading activity shows a volume of 218.57K, compared to an average daily volume of 1.09M.
The stock's 52-week range extends from a low of $0.95 to a high of $1.80.
The stock's 52-week range extends from a low of $0.95 to a high of $1.80.
Analyst ratings
100%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.